Editorials |
From the Center for Lung Biology and Department of Pharmacology, University of South Alabama, Mobile.
Correspondence to Dr Donna L. Cioffi, University of South Alabama, MSB 3362, Dept. of Pharmacology, 307 N. University Blvd., Mobile, AL 36688. E-mail dlc302{at}jaguar1.usouthal.edu
See related article, pages 10631070
Key Words: TRPV1 capsaicin adipogenesis obesity microdomains
Ive always wondered why my husband insists on growing hot peppers in the garden each year. Indeed if you pop 1 of these little bits of fire into your mouth the burning sensation that ensues is truly a memorable experience. But my husband always says that eating hot peppers is good for you. And indeed, he might be right. Hot peppers contain capsaicin, the chemical responsible for the "hot".1,2 Capsaicin is used clinically for a number of indications including pain and itch relief and for some forms of rhinitis and headache.1 It has also been implicated in playing a role in prevention of colon cancer and in antimicrobial actions against Helicobacter pylori.3 Capsaicin is a potent agonist for the TRPV1 calcium channel.1,2 TRPV1 is perhaps best known as a "molecular integrator" of noxious or painful stimuli.4 However, physiological roles not associated with pain are now becoming evident for TRPV1. In this issue of Circulation Research, Zhang and colleagues present a novel, physiological role for the TRPV1 channel in the prevention of adipogenesis and obesity.5
Obesity is a major, global health concern. According to the World Health Organization,6 there were approximately 1.6 billion overweight adults in 2005, with at least 400 million obese people. The projections are even more staggering for the year 2015 with approximately 2.3 billion overweight adults and greater than 700 million obese people. Being overweight or obese increases the risk of developing numerous deleterious health conditions including heart disease, diabetes, cancer, arthritis, and reproductive problems.7 To reverse this epidemic, the general population must become proactive to reach and maintain a healthy body weight. To this end there are numerous over-the-counter products claiming to promote weight loss. Most of these products, however, come saddled with efficacy and safety concerns. It would be desirable to identify a safe and efficacious therapy to aid in weight loss and maintenance.
During the last decade numerous articles have been published linking human capsaicin intake to factors that would aid in weight loss and maintenance. Red pepper consumption was shown to increase energy expenditure and lipid oxidation8 as well as decrease appetite.9,10 Although the mechanisms underlying these effects are not fully understood, it has been proposed that capsaicin stimulates sensory neurons in the mouth and gastrointestinal tract resulting in increased noradrenaline levels.11 Findings from Zhang and colleagues now report a second mechanism through which capsaicin may aid in weight loss. Their work suggests that capsaicin activates a TRPV1 channel, and promotes calcium entry that is necessary to prevent preadipocyte-to-adipocyte differentiation. TRPV1 activation may ultimately reduce the number and size of fat cells, and therefore reduce the propensity for obesity to develop.
TRPV1 is a member of the transient receptor potential superfamily of proteins.12,13 It is a nonselective cation channel with high calcium permeability13 and is activated by noxious stimuli including chemicals in the vanilloid class (eg, capsaicin and resiniferatoxin), elevated temperatures and protons.4 TRPV1 is highly expressed in sensory neurons, but has also been detected in numerous other tissues including the brain, pancreas, kidney and liver.4
In the current study, Zhang et al detected TRPV1 for the first time in mouse embryo 3T3-L1 preadipocytes, as well as in human and mouse visceral adipose tissue.5 Induction of adipogenesis was accompanied by a concomitant decrease in TRPV1 expression and decreased capsaicin-mediated calcium influx. In the presence of capsaicin, TRPV1 downregulation was no longer observed, the capsaicin-induced cytosolic calcium increase was maintained, and adipogenesis was prevented. Surprisingly the prolonged capsaicin treatment (8 days) did not desensitize TRPV1 channels. The authors also performed in vivo studies in which mice fed a high fat diet in the presence of capsaicin exhibited lower body weight and higher TRPV1 expression compared with mice on a high fat diet alone. In TRPV1 knock-out mice there was no significant difference in body weight between mice on a high fat diet with or without capsaicin. Collectively, data in this study provide evidence for activation of TRPV1 and increased cytosolic calcium in the prevention of adipogenesis.
Activation of the TRPV1 channel by capsaicin leads to an increase in cytosolic calcium. Several studies have implicated a role for increased cytosolic calcium in the prevention of the early phases of adipogenesis. In 3T3-L1 preadipocytes, application of the plant alkaloid thapsigargin or the calcium ionophore A23187 to increase cytosolic calcium resulted in inhibition of the early phases of differentiation.14 In human adipocytes, increases in cytosolic calcium exhibited a biphasic effect in the regulation of differentiation.15 Increases in cytosolic calcium inhibited the early stages but enhanced the late stage of differentiation. Clearly then not all increases in cytosolic calcium lead to inhibition of adipocyte differentiation. Indeed, potential downstream calcium targets include both pro- and antiadipogenic factors. The question arises then, what regulates such divergent effects of calcium signaling on adipogenesis?
It is well recognized that diverse signaling events can be regulated by localization of signaling components to specific cellular microdomains. Lipid rafts and caveolae are cholesterol-rich membrane microdomains which are important for the coalescence of signaling partners into distinct areas of the cell.16 Functional TRPV1 channels, at least in nociceptors, appear to require localization to lipid rafts.17 On activation of the TRPV1 channel, calcium pools with elevated calcium concentrations could form in the vicinity of lipid rafts containing TRPV1. It is interesting to speculate that lipid raft microdomains play a role in regulation of calcium-mediated inhibition of adipogenesis.
Lipid raft and caveolae microdomains have been implicated in the localization of a number of ion channels including store-operated calcium (SOC) channels.18 SOC entry is a unique mechanism whereby calcium channels in the plasma membrane are activated in response to depletion of calcium from the endoplasmic reticulum.19 SOC entry channels also play a role in adipogenesis. Nuclear factor of activated T cells is a transcription factor that has been shown to promote the expression of the aP2 gene and adipocyte differentiation.20 Nuclear factor of activated T cells is activated by calcium from SOC entry channels and calcineurin.21 However, SOC entry channels are also activated by thapsigargin, and increases in cytosolic calcium mediated by thapsigargin have been implicated in inhibition of the early phases of adipogenesis.14 This then presents an apparent dichotomy in the role of SOC entry channels in adipogenesis, and is an important area that needs to be resolved. Nonetheless, the global idea is that calcium pools associated with specific lipid raft microdomains may play a role in regulation of adipogenic signaling paths (Figure), and more specifically, that calcium entry through TRPV1 containing channels increases a calcium pool which transduces signals inhibiting adipogenesis.
|
Inhibition of adipogenesis and obesity through activation of TRPV1 by its agonist capsaicin is an exciting prospect. Data presented by Zhang et al provide compelling evidence supporting this idea, yet they also reveal some unresolved questions. To begin, negative feedback mechanisms have been reported for sensory neurons, where prolonged or elevated capsaicin treatment leads to desensitization of TRPV1 channels.1,22 In the gastrointestinal tract afferent neurons which are sensitive to capsaicin contribute to regulation of nociception, circulation, mucosal homeostasis, motility and secretion.23 It will be critical then to determine whether TRPV1 in neurons of the gastrointestinal tract is desensitized by levels of capsaicin required to inhibit adipogenesis, as this could lead to disturbances in normal gastrointestinal function. In addition, as TRPV1 has also been detected in numerous cell types including endothelial cells24 and smooth muscle cells,25 the downstream effects resulting from activation, and possibly desensitization, of other capsaicin-sensitive TRPV1 channels must be considered. Finally, a critical question regarding the normal physiological regulation of preadipocyte-to-adipocyte differentiation remains: what are the endogenous agonists and antagonists of preadipocyte TRPV1 channels important for regulation of adipogenesis? Considering that TRPV1 is susceptible to sensitization26 one could speculate that capsaicin is playing a role in sensitizing the TRPV1 channel to its endogenous agonist. As these and other issues become clearer, it may indeed turn out that capsaicin-mediated activation of TRPV1 is an enticing way to prevent obesity.
| Acknowledgments |
|---|
D.C. is funded by grant number 0625311B from the American Heart Association.
Disclosures
None.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
2. Tominaga M, Tominaga T. Structure and function of TRPV1. Pflugers Arch. 2005; 451: 143150.[CrossRef][Medline] [Order article via Infotrieve]
3. Szallasi A. Vanilloid (capsaicin) receptors in health and disease. Am J Clin Pathol. 2002; 118: 110121.
4. ONeil RG, Brown RC. The vanilloid receptor family of calcium-permeable channels: molecular integrators of microenvironmental stimuli. News Physiol Sci. 2003; 18: 226231.
5. Zhang LL, Liu DY, Ma LQ, Luo ZD, Cao TB, Zhong J, Yan ZC, Wang LJ, Zhao ZG, Zhu SJ, Schrader M, Thilo F, Zhu ZM, Tepel M. Activation of transient receptor potential vanilloid type-1 (TRPV1) channel prevents adipogenesis and obesity. Circ Res. 2007; 100: 10631070.
6. World Health Organization. Obesity and overweight. Available at http://www.whoint/mediacentre/factsheets/fs311/en/print.html; 2006.
7. United States Department of Health & Human Services. The Surgeon Generals Call to Action to Prevent and Decrease Overweight and Obesity. Available at http://www.surgeongeneral.gov/topics/obesity/calltoaction/fact_consequences.html; 2007.
8. Yoshioka M, St-Pierre S, Suzuki M, Tremblay A. Effects of red pepper added to high-fat and high-carbohydrate meals on energy metabolism and substrate utilization in Japanese women. Br J Nutr. 1998; 80: 503510.[Medline] [Order article via Infotrieve]
9. Westerterp-Plantenga MS, Smeets A, Lejeune MP. Sensory and gastrointestinal satiety effects of capsaicin on food intake. Int J Obes (Lond). 2005; 29: 682688.[CrossRef][Medline] [Order article via Infotrieve]
10. Yoshioka M, St-Pierre S, Drapeau V, Dionne I, Doucet E, Suzuki M, Tremblay A. Effects of red pepper on appetite and energy intake. Br J Nutr. 1999; 82: 115123.[Medline] [Order article via Infotrieve]
11. Belza A, Frandsen E, Kondrup J. Body fat loss achieved by stimulation of thermogenesis by a combination of bioactive food ingredients: a placebo-controlled, double-blind 8-week intervention in obese subjects. Int J Obes (Lond). 2007; 31: 121130.[CrossRef][Medline] [Order article via Infotrieve]
12. Montell C. The TRP superfamily of cation channels. Sci STKE. 2005.
13. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature. 1997; 389: 816824.[CrossRef][Medline] [Order article via Infotrieve]
14. Ntambi JM, Takova T. Role of Ca2+ in the early stages of murine adipocyte differentiation as evidenced by calcium mobilizing agents. Differentiation. 1996; 60: 151158.[Medline] [Order article via Infotrieve]
15. Shi H, Halvorsen YD, Ellis PN, Wilkison WO, Zemel MB. Role of intracellular calcium in human adipocyte differentiation. Physiol Genomics. 2000; 3: 7582.
16. Alonso MA, Millan J. The role of lipid rafts in signalling and membrane trafficking in T lymphocytes. J Cell Sci. 2001; 114: 39573965.[Medline] [Order article via Infotrieve]
17. Liu M, Huang W, Wu D, Priestley JV. TRPV1, but not P2X, requires cholesterol for its function and membrane expression in rat nociceptors. Eur J Neurosci. 2006; 24: 16.[CrossRef][Medline] [Order article via Infotrieve]
18. Ambudkar IS. Ca2+ signaling microdomains:platforms for the assembly and regulation of TRPC channels. Trends Pharmacol Sci. 2006; 27: 2532.[CrossRef][Medline] [Order article via Infotrieve]
19. Parekh AB. On the activation mechanism of store-operated calcium channels. Pflugers Arch. 2006; 453: 303311.[CrossRef][Medline] [Order article via Infotrieve]
20. Ho IC, Kim JH, Rooney JW, Spiegelman BM, Glimcher LH. A potential role for the nuclear factor of activated T cells family of transcriptional regulatory proteins in adipogenesis. Proc Natl Acad Sci U S A. 1998; 95: 1553715541.
21. Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 2003; 17: 22052232.
22. Liu B, Zhang C, Qin F. Functional recovery from desensitization of vanilloid receptor TRPV1 requires resynthesis of phosphatidylinositol 4,5-bisphosphate. J Neurosci. 2005; 25: 48354843.
23. Holzer P. TRPV1 and the gut: from a tasty receptor for a painful vanilloid to a key player in hyperalgesia. Eur J Pharmacol. 2004; 500: 231241.[CrossRef][Medline] [Order article via Infotrieve]
24. Yao X, Garland CJ. Recent developments in vascular endothelial cell transient receptor potential channels. Circ Res. 2005; 97: 853863.
25. Yang XR, Lin MJ, McIntosh LS, Sham JS. Functional expression of transient receptor potential melastatin- and vanilloid-related channels in pulmonary arterial and aortic smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2006; 290: L1267L1276.
26. Immke DC, Gavva NR. The TRPV1 receptor and nociception. Semin Cell Dev Biol. 2006; 17: 582591.[CrossRef][Medline] [Order article via Infotrieve]
Related Article:
Circ. Res. 2007 100: 1063-1070.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |